Emerging Trends in Biomedical and Health Sciences
- co11ab
-
medtech, digitalhealth, investment, invest, technologies, trends, biotech
- 14 August 2024
Investment landscape report and next generation of healthcare technologies.
“Coffee with X” Series – legal consultation by fsLAW
- co11ab
-
consultation, coffeewithX, legal
- 29 July 2024
Legal consultation to address startups' needs.
Medtech bench testing and regulatory strategies
- co11ab
-
medtech, regulatory, qms, quality management system
- 24 July 2024
Build rapport with regulators to ensure smoother process of document submissions.
Intranasal splint approval by Health Science Authority
- co11ab
-
biomaterials, biopolymers, IntranasalSplint, biotech, medtech, HSAapproval
- 31 May 2024
Intranasal Splint Approval by HSA.
VC investment agreements for biomedtech entrepreneurs
- co11ab
-
digitalhealth, investment, founders, contracts, agreements, equity, biotech, medtech
- 16 May 2024
Demystifying the complexities of VC investment agreements.
Nucleate Ignite Series – Educational series aimed to convey in-depth technical understanding of crucial roles in the biotech world
- co11ab
-
biotech, IP, drugdiscovery, Biotherapeutics, productdevelopment, regulatory
- 22 February 2024
The processes involved in creating a therapeutic program in biotech and pharma companies, and how it differs from academic science.
Cantabio Pharmaceuticals awarded grant from the Michael J. Fox Foundation to develop novel DJ-1 protein replacement therapy for the treatment of PD
- co11ab
-
biotech, drugdiscovery, cantabio, PD, parkinson
- 07 February 2024
Grant enables further development of Cantabio's innovative DJ-1 replacement therapy for the treatment of Parkinson's disease
Women health med-tech Biorithm bags US$3.5 million in Series A
- co11ab
-
biorithm, women, pregnancy, fetal, medtech, womenhealth
- 18 December 2023
Expanding clinical trial footprint to more market and accelerate commercialisation in the US
KINS raised 15M SGD in Sep’2023 through private placement and bank loans, bringing total funding of 30M SGD
- co11ab
-
biotech, skincare, skin, microbiome, kins
- 04 October 2023
KINS is planning to commercialize proprietary microbiome strains and expand research capability
